Ross Michael Jay 4
4 · Xilio Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
ROSS MICHAEL JAY
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+13,200→ 13,200 totalExercise: $2.28Exp: 2032-06-14→ Common Stock (13,200 underlying)
Footnotes (1)
- [F1]The option award was granted on June 15, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 15, 2023 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date.